Sodium, Glucose and Dysregulated Glucagon Secretion: The Potential of Sodium Glucose Transporters
Diabetes is defined by hyperglycaemia due to progressive insulin resistance and compromised insulin release. In parallel, alpha cells develop dysregulation of glucagon secretion. Diabetic patients have insufficient glucagon secretion during hypoglycaemia and a lack of inhibition of glucagon secretio...
Main Authors: | Sarah L. Armour, Alexander Frueh, Jakob G. Knudsen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.837664/full |
Similar Items
-
Comparative study of sodium-dependent glucose co-transporters in kidneys of Ostrich chickens
by: Piret Hussar, et al.
Published: (2022-07-01) -
A review on the medicinal chemistry of sodium glucose co-transporter 2 inhibitors (SGLT2-I): Update from 2010 to present
by: Jonali Ramani, et al.
Published: (2022-12-01) -
Short Communication: Immunohistochemical study of sodium-dependent glucose co-transporters in ostriches kidneys
by: Piret Hussar, et al.
Published: (2020-12-01) -
Sodium glucose co-transporter 2 inhibitors in heart failure therapy
by: Yüksel Çavuşoğlu, et al.
Published: (2020-04-01) -
The metabolic model of heart failure: the role of sodium glucose co-transporter-2 (SGLT-2) inhibition
by: Muhammad Saad, et al.
Published: (2018-11-01)